Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome

NCT00471731 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT00471731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00471731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome
Lead sponsor
National Eye Institute (NEI)
Phase
Observational
Overall status
Completed
Start date
May 7, 2007
Completion date
November 13, 2014
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

menopause, ovarian failure, premature, perimenopause, sex chromosome aberrations, turner syndrome